Subtype
Brain Neoplasm
CI-CAN-00002030Explore in graph →
Non-malignant512 active trials34 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002030Explore in graph →
Clinical trials
2,118 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06328686 | Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases | recruiting | Early Phase 1 | 10 | Emory UniversityOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT07177482 | ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients | recruiting | N/A | 20 | Deling LiOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT07179328 |
| Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy |
| recruiting |
| Phase 1 |
| 10 |
| Sunnybrook Health Sciences CentreOTHER |
| 1 |
| Sep 17, 2025 |
| clinicaltrials |
| NCT02887040 | Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma(DIPG) | not yet recruiting | Phase 3 | 92 | Burzynski Research InstituteOTHER | 0 | Sep 16, 2025 | clinicaltrials |
| NCT05014841 | The Neural Coding of Speech Across Human Languages | enrolling by invitation | N/A | 52 | University of California, San FranciscoOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT06831461 | Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors(PRIDE) | recruiting | N/A | 156 | Tata Memorial CentreOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT03958240 | Deciphering Mechanisms Underlying Cancer Immunogenicity(DECIDE) | recruiting | N/A | 1,100 | Institut Claudius RegaudOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT06020066 | SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI | active not recruiting | Phase 2 | 202 | Fudan UniversityOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT07170436 | Brain Areas of Cognitive Functions: a Study in Awake Surgery(BRAIN-MAP) | not yet recruiting | N/A | 120 | University Hospital, ToulouseOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT06552260 | A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma | recruiting | Early Phase 1 | 27 | Ugonma ChukwuekeOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT07167134 | Evolution of Hypofractionated Stereotactic Irradiation for Radio-Resistant Brain Metastases From D1-3-5 to D1-2-3(SISMIC) | not yet recruiting | Phase 3 | 264 | Centre Paul StraussOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT07165262 | Effect of Different Anesthetic Drugs on Electrocorticography (ECOG).(ECOG-Anaes) | active not recruiting | Phase 3 | 88 | Children's Cancer Hospital Egypt 57357OTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT05622409 | A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma | recruiting | — | 250 | National Health Research Institutes, TaiwanOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT07158710 | Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation | recruiting | Phase 1 | 159 | Haisco Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Sep 8, 2025 | clinicaltrials |
| NCT06309251 | Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients | recruiting | — | 100 | Danone Nutricia SpA Società BenefitINDUSTRY | 1 | Sep 3, 2025 | clinicaltrials |
| NCT02670161 | Quality Improvement and Practice Based Research in Neurology Using the EMR | enrolling by invitation | Phase 4 | 3,300 | Endeavor HealthOTHER | 1 | Aug 24, 2025 | clinicaltrials |
| NCT07140601 | Environmental Pollutants and Neurological Disorders(CLEAN) | recruiting | — | 500 | Beijing Tiantan HospitalOTHER | 1 | Aug 24, 2025 | clinicaltrials |
| NCT06471465 | Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases(BRADI) | recruiting | Phase 3 | 84 | Institut Cancerologie de l'OuestOTHER | 1 | Aug 17, 2025 | clinicaltrials |
| NCT07126821 | A Vision-Language Foundation Model for Brain Disease Diagnosis From Multimodal Data | recruiting | — | 100,000 | Xiangya Hospital of Central South UniversityOTHER | 1 | Aug 17, 2025 | clinicaltrials |
| NCT07122752 | Feasibility and Outcomes of 3D-printed External Cranial Orthosis After Craniectomy | active not recruiting | — | 32 | Tan Tock Seng HospitalOTHER | 1 | Aug 14, 2025 | clinicaltrials |
| NCT04833335 | ASL in Brain Metastasis MRI Following Gamma Knife Treatment(GK-ASL) | recruiting | N/A | 60 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT05947149 | HRQoL in Patients With Solid Tumors Treated With Hadrontherapy(HadroQoL) | recruiting | — | 180 | CNAO National Center of Oncological HadrontherapyOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT07023640 | Application of the CD73-Targeted Probe ⁶⁸Ga-DOTA-mPNE PET/CT Imaging in the Diagnosis of Malignant Tumors | recruiting | N/A | 50 | Peking Union Medical College HospitalOTHER | 1 | Aug 5, 2025 | clinicaltrials |
| NCT06727032 | Automated Detection of Brain Metastases on MRI(BrainMets AI) | enrolling by invitation | — | 12 | Robovision BVINDUSTRY | 1 | Aug 3, 2025 | clinicaltrials |
| NCT06299891 | Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity | recruiting | Phase 2 | 24 | Seattle Children's HospitalOTHER | 1 | Jul 28, 2025 | clinicaltrials |
| NCT04135807 | Implantable Microdevice In Primary Brain Tumors | recruiting | Early Phase 1 | 12 | Oliver JonasOTHER | 1 | Jul 23, 2025 | clinicaltrials |
| NCT01843413 | Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases | active not recruiting | Phase 1 | 33 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT06501521 | Non-invasive Brain Tumor Molecular Diagnostics and Monitoring | recruiting | — | 200 | The Institute of Molecular and Translational Medicine, Czech RepublicOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT06092125 | Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease(CAMIND) | recruiting | — | 2,300 | Xuanwu Hospital, BeijingOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT06457906 | SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC(SHARP) | recruiting | Phase 3 | 340 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT06099743 | ASCENT Intervention for Brain Tumor Patients | recruiting | N/A | 100 | Massachusetts General HospitalOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT06128148 | Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors(JYP0322) | recruiting | Phase 1 | 101 | Guangzhou JOYO Pharma Co., LtdINDUSTRY | 1 | Jul 14, 2025 | clinicaltrials |
| NCT03893487 | Fimepinostat in Treating Brain Tumors in Children and Young Adults(PNOC016) | active not recruiting | Early Phase 1 | 30 | Sabine Mueller, MD, PhDOTHER | 2 | Jul 11, 2025 | clinicaltrials |
| NCT07049094 | The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy | recruiting | Phase 4 | 218 | Zhejiang UniversityOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT03175224 | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors(SPARTA) | recruiting | Phase 2 | 497 | Apollomics Inc.INDUSTRY | 11 | Jun 27, 2025 | clinicaltrials |
| NCT06896110 | Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma | enrolling by invitation | Phase 1 | 34 | Andrew P. GrovesOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT07034859 | Cabergoline in the Management of Nonfunctioning Pituitary Adenoma | enrolling by invitation | Phase 4 | 30 | National Taiwan University HospitalOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT04111588 | Diagnostic Assessment of Amino Acid PET/MRI in the Evaluation of Glioma and Brain Metastases | recruiting | — | 160 | Norwegian University of Science and TechnologyOTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT06951659 | Investigating Visual Verticality Disorder and Lateropulsion in a Neurosurgical Cohort of Patients With Brain Tumours | recruiting | — | 100 | The University of Western AustraliaOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT04785521 | Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery | active not recruiting | — | 100 | IRCCS San RaffaeleOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT05831631 | Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors | recruiting | — | 200 | Pietro Mortini, MD, Prof.OTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT06263361 | Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma. | recruiting | — | 15 | IRCCS San RaffaeleOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT04847284 | Intraoperative Radiotherapy in Patients With Brain Metastases | recruiting | N/A | 25 | Parc de Salut MarOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT06992973 | Efficacy of the Association of Fractionated SRS and Subsequent Surgery in Patients With Brain Metastases | recruiting | N/A | 98 | Regina Elena Cancer InstituteOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT05477680 | Intraoperative Brain Shift Calculation Study(BRASH) | recruiting | N/A | 100 | Sklifosovsky Institute of Emergency CareOTHER_GOV | 1 | May 16, 2025 | clinicaltrials |
| NCT05484245 | Sonography-guided Resection of Brain Mass Lesions(SOMALI) | recruiting | N/A | 100 | Sklifosovsky Institute of Emergency CareOTHER_GOV | 1 | May 16, 2025 | clinicaltrials |
| NCT06973824 | A Twenty-years' Experience in Pituitary Disease.(TYEPDD) | recruiting | — | 1,600 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT05397873 | Biofeedback for Hemianopia Vision Rehabilitation | recruiting | N/A | 32 | University Health Network, TorontoOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT05179824 | Tempus Priority Study: A Pan-tumor Observational Study | active not recruiting | — | 1,000 | Tempus AIINDUSTRY | 1 | May 6, 2025 | clinicaltrials |
| NCT06401824 | Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases | recruiting | Phase 2 | 25 | Maastricht University Medical CenterOTHER | 1 | May 6, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Sep 17, 2025source: clinicaltrials